Sangel Capital
Venture capitalShenzhen · Seed–Late Stage
Investment thesis
Sangel Venture concentrates on the life science and technology sector, positioning itself as one of China's earliest professional biomedical venture investors. Drawing on deep industry expertise and project resources, it identifies innovative growth-stage enterprises with strong capital value and commercial potential, aiming to build benchmark companies across subdivided segments of the biomedical industry. The firm assembles investment and advisory teams of industry experts, scientists, and investors in life technology to manage a series of both RMB- and USD-denominated funds.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 6 of 13 portfolio companiesBiotech ×5Healthtech ×3Medical Devices ×3Advanced Manufacturing ×1AI & Machine Learning ×1B2B Marketplaces ×1Deep Tech ×1Digital Health ×1
HQs:China×2United States×1
Investments · 13 tracked
founders shown can be your intro pathBeyondSpring is a clinical-stage pharmaceutical company developing Plinabulin, a cancer drug candidate studied for reducing chemotherapy-induced neutropenia and, in combination with radiation and PD-1/PD-L1 inhibitors, treating patients who failed prior immune checkpoint therapy.
BiotechHealthtech
Co-investorsDecheng Capital
Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)Robert Carson(Executive Officer, Director)Rob Carson(Chief Executive Officer)in
Co-investorsARCH Venture PartnersNorthpond Ventures6 Dimensions CapitalApplied VenturesKilonova CapitalPura Vida Investments+2 more
KBP Biosciences is a biotechnology research and development organization that discovers and develops innovative therapeutic drugs for unmet medical needs using an integrated discovery and development platform.
Biotech
Lookchem operates a vertical integration trading platform for chemicals, offering services from laboratory custom synthesis and R&D scale-up to process optimization and commercial production, providing a stable supply chain and ecosystem for global customers.
Advanced ManufacturingB2B Marketplaces
Aucta develops therapeutics and drug delivery technologies based on proven molecular compounds.
BiotechDigital HealthMedical Devices
Uni-medica develops molecular diagnostic systems and reagents for infectious disease, genetic disorder, and cervical cancer screening applications.
BiotechHealthtechMedical DevicesShenzhen, CN
Portfolio news
latest coverage across their companiesBeyondSpring Pharmaceuticals · themarketsdaily.com · Jul 29, 2026
Frequently asked questions
- How many investments has Sangel Capital made?
- Sangel Capital has 12 tracked investments.
- What stage does Sangel Capital invest at?
- Sangel Capital invests at the Seed, Series A, Growth, Late Stage stages.
- What sectors does Sangel Capital focus on?
- Sangel Capital focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Sangel Capital located?
- Sangel Capital is headquartered in Shenzhen, CN.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Ally Bridge Group is a global healthcare investment manager focused on high-impact life sciences innovation across private and public markets.